Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2697 |
|
Actual shortage: | 241 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2447 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2023-06-08 | 2023-07-05 | 194167 |
TEVA-ESCITALOPRAM | 10MG | TABLET | Resolved | 2023-06-16 | 2023-06-27 | 195133 |
ACT MEMANTINE | 10MG | TABLET | Resolved | 2023-06-16 | 2023-07-07 | 195180 |
TEVA-PROPRANOLOL | 10MG | TABLET | Resolved | 2023-06-16 | 2023-07-06 | 195213 |
TEVA-PROPRANOLOL | 10MG | TABLET | Resolved | 2023-06-16 | 2023-07-05 | 195234 |
TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2023-06-19 | 2024-05-30 | 195456 |
TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2023-06-19 | 2024-05-30 | 195481 |
TEVA-AMPHETAMINE XR | 10MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-06-20 | 2023-07-06 | 195876 |
TEVA-OLANZAPINE | 10MG | TABLET | Avoided shortage | 2023-07-20 | 2023-08-17 | 199365 |
TEVA-ROSUVASTATIN | 10MG | TABLET | Resolved | 2023-07-20 | 2024-01-19 | 199398 |
TEVA-ROSUVASTATIN | 10MG | TABLET | Resolved | 2023-07-27 | 2024-01-19 | 200290 |
TEVA-CLOBAZAM | 10MG | TABLET | Resolved | 2023-08-18 | 2023-10-04 | 202490 |
TEVA-SIMVASTATIN | 10MG | TABLET | Actual shortage | 2023-10-05 | 2024-05-03 | 206401 |
TEVA-RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2023-10-05 | 2023-11-09 | 206428 |
TEVA-DOMPERIDONE | 10MG | TABLET | Resolved | 2023-10-19 | 2023-11-30 | 207506 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2023-11-03 | 2024-01-25 | 209125 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2023-11-03 | 2023-11-23 | 209130 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2023-11-03 | 2024-01-25 | 209133 |
TEVA-ATOMOXETINE | 10MG | CAPSULE | Resolved | 2023-11-09 | 2023-12-14 | 209669 |
TEVA-OLANZAPINE | 10MG | TABLET | Resolved | 2023-11-16 | 2023-12-14 | 210434 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
ACT CLOPIDOGREL | Discontinued | 2018-10-19 | 2018-10-19 | 65065 | ||
ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65284 | ||
ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65289 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81330 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81337 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 | ||
HYDROCORTISONE SODIUM SUCCINATE INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81347 | ||
TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106136 | ||
TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106139 | ||
RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 | ||
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 | ||
TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION | 0.004% | SOLUTION | Discontinued | 2020-01-21 | 2020-01-21 | 103788 |
TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
RATIO-TAMSULOSIN | 0.4MG | CAPSULE (SUSTAINED-RELEASE) | Discontinued | 2018-10-19 | 2018-10-19 | 64917 |